Press Release

Acadia Healthcare Reports First Quarter Adjusted EPS of $0.11 and EPS of $0.10 on Revenues of $91.3 Million

Affirms Earnings Guidance for 2012 in Range of $0.65 to $0.67 per Diluted Share

Names Brent Turner President and Hires Steve Davidson as Chief Development Officer

FRANKLIN, Tenn.--(BUSINESS WIRE)--Apr. 27, 2012-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2012. Revenue for the first quarter was $91.3 million compared with $16.8 million for the first quarter of 2011. Adjusted net income from continuing operations was $3.5 million, or $0.11 per diluted share, for the first quarter of 2012, which excludes transaction related fees, compared with $1.3 million, or $0.07 per diluted share, for the first quarter last year, which excludes transaction related fees and sponsor management fees. Including these costs, income from continuing operations was $3.4 million, or $0.10 per diluted share, for the latest quarter compared with a loss from continuing operations for the first quarter of 2011 of $0.3 million, or $0.01 per diluted share. A reconciliation of all GAAP and non-GAAP financial results in this release is on pages 7 and 8.

"The strong profitable growth Acadia produced for the first quarter of 2012 represents a solid step toward achieving our financial guidance for the full year," remarked Joey Jacobs, Chairman and Chief Executive Officer of Acadia. "With the acquisition of three facilities with 166 acute inpatient psychiatric beds during the first quarter, we completed the quarter operating 33 facilities with over 2,100 beds in 19 states, up from six facilities and approximately 400 beds in five states at the end the first quarter of 2011.

"While we will continue to evaluate select acquisition opportunities in a highly fragmented market, we are focused on producing organic revenue growth and margin expansion within our existing facilities through the addition of beds, the broadening of services, enhanced marketing programs and efficiency improvement initiatives. The margin opportunity in executing these initiatives well is reflected in a 24.6% same-facility EBITDA margin for the first quarter of 2012 for our six legacy facilities compared with the 20.7% EBITDA margin for all facilities. With improving operating leverage, we also expect to expand our consolidated EBITDA margin, which increased to 16.7% of revenue for the latest quarter from 15.4% for the first quarter last year.

"Our profitable growth supports our ability to fund our organic growth initiatives and acquisition strategy, as well as our relatively low annual maintenance capital expenditures of approximately 2% of revenues. In addition to our substantial cash flow from operations, we also have availability of approximately $68 million under our revolving line of credit at the end of the first quarter.

"We are pleased to announce that Brent Turner, formerly Co-President of the Company, has been named President of Acadia and that Steve Davidson has joined Acadia as Chief Development Officer. Both of these men are experienced, highly capable leaders, who were instrumental in the successful development of Psychiatric Solutions, Inc., among other business achievements. I am confident of their ability to excel in their new positions, and we congratulate them on their appointments."

Acadia today confirmed its guidance for 2012 earnings per diluted share in a range of $0.65 to $0.67. The Company's guidance does not include the impact of any future acquisitions.

Acadia will hold a conference call to discuss its first quarter financial results at 9:00 a.m. Eastern Time on Friday, April 27, 2012. A live webcast of the conference call will be available at http://www.acadiahealthcare.com in the "Investors" section of the website or at http://www.earnings.com. The webcast of the conference call will be available through May 11, 2012.

Risk Factors

This news release contains forward-looking statements. Generally words such as "may," "will," "should," "could," "anticipate," "expect," "intend," "estimate," "plan," "continue," and "believe" or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this news release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) Acadia's ability to complete acquisitions and successfully integrate the operations of the acquired facilities; (ii) Acadia's ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from the government and third-party payors; (iv) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; and (v) potential operating difficulties, client preferences, changes in competition and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategy. These factors and others are more fully described in Acadia's periodic reports and other filings with the SEC.

About Acadia

Acadia is a provider of inpatient behavioral health care services. Acadia operates a network of 33 behavioral health facilities with over 2,100 licensed beds in 19 states. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.

Acadia Healthcare Company, Inc.
Consolidated Statements of Operations
(Unaudited)

	Three Months Ended March 31,

	2012			2011
	(in thousands, except per share amounts)

Revenue before provision for doubtful accounts	$	93,021		$	17,584
Provision for doubtful accounts		(1,723	)		(738	)
Revenue		91,298			16,846

Salaries, wages and benefits (including equity-based compensation expense of $578 and $0 for the three months ended March 31, 2012 and 2011, respectively)		56,540			10,712

Professional fees		4,216			375
Supplies		4,457			933
Rents and leases		2,320			351
Other operating expenses		9,140			1,886
Depreciation and amortization		1,615			243
Interest expense, net		7,282			223
Sponsor management fees		-			45
Transaction-related expenses		695			2,606
Total expenses		86,265			17,374
Income (loss) from continuing operations before income taxes		5,033			(528	)
Provision (benefit) for income taxes		1,665			(271	)
Income (loss) from continuing operations		3,368			(257	)
Income from discontinued operations, net of income taxes		311			8
Net income (loss)	$	3,679		$	(249	)

Basic earnings per share:
Income (loss) from continuing operations	$	0.10		$	(0.01	)
Income from discontinued operations	$	0.01		$	-
Net income (loss)	$	0.11		$	(0.01	)

Diluted earnings per share:
Income (loss) from continuing operations	$	0.10		$	(0.01	)
Income from discontinued operations	$	0.01		$	-
Net income (loss)	$	0.11		$	(0.01	)

Shares outstanding:
Basic		32,120			17,633
Diluted		32,333			17,633

Acadia Healthcare Company, Inc.
Consolidated Balance Sheets


	(Unaudited)
	March 31, 2012			December 31, 2011
	(In thousands, except share and per share amounts)

ASSETS
Current assets:
Cash and cash equivalents	$	840		$	61,118
Accounts receivable, net of allowance for doubtful accounts of $3,575 and $2,424, respectively		43,802			35,127
Deferred tax asset		5,683			6,239
Other current assets		11,897			10,121
Total current assets		62,222			112,605
Property and equipment, net		98,290			82,972
Goodwill		261,421			186,815
Intangible assets, net		9,381			8,232
Deferred tax asset - long-term		5,016			6,006
Other assets		16,922			16,366
Total assets	$	453,252		$	412,996


LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	8,000		$	6,750
Accounts payable		8,074			8,642
Accrued salaries and benefits		16,542			16,195
Other accrued liabilities		14,110			9,081
Total current liabilities		46,726			40,668
Long-term debt		299,514			270,709
Other liabilities		6,332			5,254
Total liabilities		352,572			316,631
Equity:
Preferred stock, $0.01 par value; 10,000,000 shares authorized; no shares issued		-			-
Common stock, $0.01 par value; 100,000,000 shares authorized; 32,128,474 and 32,115,929 issued and outstanding at March 31, 2012 and December 31, 2011, respectively		321			321
Additional paid-in capital		141,260			140,624
Accumulated deficit		(40,901	)		(44,580	)
Total equity		100,680			96,365
Total liabilities and equity	$	453,252		$	412,996

Acadia Healthcare Company, Inc.
Consolidated Statements of Cash Flows
(Unaudited)

	Three Months Ended March 31,
	2012			2011
	(In thousands)

Operating activities:
Net income (loss)	$	3,679		$	(249	)
Adjustments to reconcile net income (loss) to net cash provided by continuing operating activities:
Depreciation and amortization		1,615			243
Provision for bad debts		1,723			738
Amortization of debt issuance costs		587			-
Equity-based compensation expense		578			-
Deferred income tax expense		1,546			233
Other		19			-
Income from discontinued operations, net of taxes		(311	)		(8	)
Change in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		(6,354	)		(2,009	)
Other current assets		(644	)		(866	)
Other assets		(40	)		-
Accounts payable and other accrued liabilities		3,491			2,848
Accrued salaries and benefits		(1,312	)		(406	)
Other liabilities		874			48
Net cash provided by continuing operating activities		5,451			572
Net cash (used in) provided by discontinued operating activities		(516	)		18
Net cash provided by operating activities		4,935			590

Investing activities:
Cash paid for acquisitions, net of cash acquired		(90,400	)		-
Cash paid for capital expenditures		(3,911	)		(784	)
Other		88			-
Net cash used in investing activities		(94,223	)		(784	)

Financing activities:
Borrowings on long-term debt		25,000			-
Net increase in revolving credit facility		7,000			-
Principal payments on long-term debt		(2,000	)		(23	)
Payment of debt issuance costs		(1,048	)		-
Proceeds from stock option exercises		58			-
Distributions to equity holders		-			(375	)
Net cash provided by (used in) financing activities		29,010			(398	)

Net decrease in cash and cash equivalents		(60,278	)		(592	)
Cash and cash equivalents at beginning of the period		61,118			8,614
Cash and cash equivalents at end of the period	$	840		$	8,022

Effect of acquisitions:
Assets acquired, excluding cash	$	93,131		$	-
Liabilities assumed		(2,731	)		-
Cash paid for acquisitions, net of cash acquired	$	90,400		$	-

Acadia Healthcare Company, Inc.
Operating Statistics
(Unaudited)
(Revenue in thousands)

	Three months ended March 31,
	2012			2011			% Change
Same Facility Results
Revenue	$	19,165		$	16,846		13.8	%
Patient Days		29,015			25,214		15.1	%
Admissions		2,145			1,864		15.1	%
Average Length of Stay (a)		13.5			13.5		0.0	%

Revenue per Patient Day	$	661		$	668		-1.1	%
EBITDA margin		24.6	%		24.3	%	30 bps

Total Facility Results
Revenue	$	91,298		$	16,846		442.0	%
Patient Days		152,645			25,214		505.4	%
Admissions		6,718			1,864		260.4	%
Average Length of Stay (a)		22.7			13.5		68.0	%

Revenue per Patient Day	$	598		$	668		-10.5	%
EBITDA margin		20.7	%		24.3	%	-360 bps


(a) Average length of stay is defined as patient days divided by admissions

Acadia Healthcare Company, Inc.
Reconciliation of Net Income (Loss) to Adjusted EBITDA
(Unaudited)

	Three Months Ended March 31, 2012			Three Months Ended March 31, 2011
	(in thousands)

Net income (loss)	$	3,679		$	(249	)
Income from discontinued operations		(311	)		(8	)
Provision (benefit) from income taxes		1,665			(271	)
Interest expense, net		7,282			223
Depreciation and amortization		1,615			243
EBITDA		13,930			(62	)

Adjustments:
Equity-based compensation expense (a)		578			-
Transaction-related expenses (b)		695			2,606
Sponsor management fees (c)		-			45
Adjusted EBITDA	$	15,203		$	2,589

See footnotes on page 9.

Acadia Healthcare Company, Inc.
Reconciliation of Adjusted Income from Continuing Operations to Income (Loss) from
Continuing Operations
(Unaudited)

	Three Months Ended March 31, 2012			Three Months Ended March 31, 2011
	(in thousands, except per share amounts)

Income (loss) from continuing operations	$	3,368		$	(257	)
Provision (benefit) from income taxes		1,665			(271	)
Income (loss) from continuing operations before income taxes		5,033			(528	)

Adjustments to income (loss) from continuing operations:
Transaction-related expenses (b)		695			2,606
Sponsor management fees (c)		-			45
Tax effect of adjustments to net loss from continuing operations (d)		(2,234	)		(849	)
Adjusted income from continuing operations	$	3,494		$	1,274

Weighted-average shares outstanding - diluted		32,333			17,633

Adjusted income from continuing operations per diluted share	$	0.11		$	0.07

See footnotes on page 9.

Footnotes

We have included certain financial measures in this press release, including EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations, which are "non-GAAP financial measures" as defined under the rules and regulations promulgated by the SEC. We define EBITDA as net income (loss) adjusted for income from discontinued operations, net interest expense, income tax provision (benefit) and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for equity-based compensation expense, transaction-related expenses, and sponsor management fees.

EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States ("GAAP"). EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations are not measures of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as measures of our liquidity. Our measurements of EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations in this press release because we believe that such information is used by certain investors as measures of a company's historical performance. We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations when reporting their results. Our presentation of EBITDA, Adjusted EBITDA and Adjusted net income from continuing operations should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

(a) Represents the equity-based compensation expense of Acadia.

(b) Represents transaction-related expenses incurred by Acadia related to the acquisitions of Youth and Family Centered Services, Inc. ("YFCS") in April 2011, PHC, Inc. ("PHC") in November 2011 and three facilities from Haven Behavioral Healthcare Holdings, LLC (the "Haven Facilities") in March 2012.

(c) Represents the management fees paid by Acadia to its equity sponsor prior to the termination of the professional services agreement between Acadia and its equity sponsor on November 1, 2011.

(d) Represents the aggregate tax effect of the adjustments to the income (loss) from continuing operations described above based on expected combined federal and state tax rates.

Source: Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.
Brent Turner, 615-861-6000
President